Page results
-
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.
-
People with obesity whose weight and health improve following drug treatment are likely to need the treatment long term, according to a UCLH and UCL study.
-
'Bolus: education delivered stat' is a podcast exploring the haematology speciality, created for nurses, junior doctors and allied healthcare professionals.
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
Prescilia from Hackney was one of the first patients to be treated at the UCLH proton beam therapy centre which opened in December 2021.
-
UCLH has signed a landmark agreement with UCL and UCL Business, the university’s technology transfer company. The agreement will simplify the commercialisation of any joint research and innovation, and ensure that any financial proceeds are shared equally. It will also make negotiations frictionless and put an end to complex deal-by-deal negotiations.
-
UCLH has moved one step closer to carbon net zero emissions with the installation of six new mobile Entonox destructions units across our birthing centre and labour wards.
-
UCLH Charity’s magazine, Charity Matters is out now.
-
Information for outpatients visiting UCLH hospitals.
File results
-
FOI/2023/0831 - Treatments for acute myeloid leukaemia/ chronic lymphocytic leukaemia
-
FOI/2023/0832 - Hospital admissions for vaping related disorders
-
FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department
-
FOI/2023/0836 - Translation services and technologies
-
FOI/2023/0837 - Treatment for Myelofibrosis
-
FOI/2023/0840 - Deaths in accident and emergency 2018-2023
-
FOI/2023/0842 - Acquired Brain Injury condition daily fees/ spend per patient
-
FOI/2023/0845 - Treatement for gastric and gastro-oesophageal junction/ Oesophageal/ ovarian cancers
-
FOI/2023/0849 - Physician Associates
-
FOI/2023/0870 - Cancer treatments cancelled or rescheduled